Technology assessment and cost-effectiveness analysis: misguided guidelines?
- PMID: 8448706
- PMCID: PMC1490754
Technology assessment and cost-effectiveness analysis: misguided guidelines?
Comment in
-
Tentative guidelines for using clinical and economic evaluations revisited.CMAJ. 1993 Mar 15;148(6):927-9. CMAJ. 1993. PMID: 8448707 Free PMC article. No abstract available.
Comment on
-
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.CMAJ. 1992 Feb 15;146(4):473-81. CMAJ. 1992. PMID: 1306034 Free PMC article.
Similar articles
-
Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.CMAJ. 1993 Mar 15;148(6):913-7. CMAJ. 1993. PMID: 8448705 Free PMC article.
-
Tentative guidelines for using clinical and economic evaluations revisited.CMAJ. 1993 Mar 15;148(6):927-9. CMAJ. 1993. PMID: 8448707 Free PMC article. No abstract available.
-
On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.Health Econ. 2002 Apr;11(3):185-91. doi: 10.1002/hec.706. Health Econ. 2002. PMID: 11921316 No abstract available.
-
Basic concepts and fundamental issues in technology assessment.Intensive Care Med. 1993;19(2):117-21. doi: 10.1007/BF01708374. Intensive Care Med. 1993. PMID: 8486866 Review. No abstract available.
-
Challenges ahead for federal technology assessment.Health Aff (Millwood). 2007 Mar-Apr;26(2):w150-2. doi: 10.1377/hlthaff.26.2.w150. Epub 2007 Jan 26. Health Aff (Millwood). 2007. PMID: 17259197 Review.
Cited by
-
Multi-attribute preference functions. Health Utilities Index.Pharmacoeconomics. 1995 Jun;7(6):503-20. doi: 10.2165/00019053-199507060-00005. Pharmacoeconomics. 1995. PMID: 10155336 Review.
-
The emerging government requirement for economic evaluation of pharmaceuticals.Pharmacoeconomics. 1994;6 Suppl 1:42-50. doi: 10.2165/00019053-199400061-00012. Pharmacoeconomics. 1994. PMID: 10155586
-
Technology assessment of anaesthesia monitors: problems and future directions.Can J Anaesth. 1995 Mar;42(3):234-9. doi: 10.1007/BF03010685. Can J Anaesth. 1995. PMID: 7743578 Review.
-
Ontario's formulary committee: how recommendations are made.Pharmacoeconomics. 2003;21(4):285-94. doi: 10.2165/00019053-200321040-00006. Pharmacoeconomics. 2003. PMID: 12600223
-
Interpretation of cost-effectiveness analyses.J Gen Intern Med. 1998 Oct;13(10):716-7. doi: 10.1046/j.1525-1497.1998.00211.x. J Gen Intern Med. 1998. PMID: 9798822 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources